Data are presented as medians (IQR) or n (%) according to the
corresponding conditions.
* All p values were calculated using univariate unconditional logistic
regression for the characteristics between the patients with normal
cumulative LB and those with cumulative LBAI, but two independent
samples (unpaired) Student’s t-test was used to compare the median ages.
** It is not applicable due to the no individuals with abnormal ALT or
AST or TBIL in Normal cumulative LB group.
†Referred to exposure to confirmed COVID-19 patients.
†† ORs were calculated using univariate unconditional logistic
regression.
‡Comorbidities were defined as history of at least one disease out of
the following: hypertension, diabetes, cardiovascular disease,
cerebrovascular disease, chronic renal disease, chronic respiratory
disease, and chronic liver disease.
§ Four patients reported history of either fatty liver or cirrhosis.
COVID-19, coronavirus disease 2019; LB, liver biochemistry; LBA, liver
biochemical abnormality; ALI, acute liver injury; LBAI, liver
biochemical abnormality or injury; ALT, alanine aminotransferase; AST,
aspartate aminotransferase; CURB-65, confusion, uremia, respiratory
rate, blood pressure, and age ≥65; IQR, interquartile range; NA, none
applicable; OR, odds ratio; CI, confidence interval; qSOFA, the Quick
Sequential Organ Failure Assessment.
|
Data are presented as medians (IQR) or n (%) according to the
corresponding conditions.
* All p values were calculated using univariate unconditional logistic
regression for the characteristics between the patients with normal
cumulative LB and those with cumulative LBAI, but two independent
samples (unpaired) Student’s t-test was used to compare the median ages.
** It is not applicable due to the no individuals with abnormal ALT or
AST or TBIL in Normal cumulative LB group.
†Referred to exposure to confirmed COVID-19 patients.
†† ORs were calculated using univariate unconditional logistic
regression.
‡Comorbidities were defined as history of at least one disease out of
the following: hypertension, diabetes, cardiovascular disease,
cerebrovascular disease, chronic renal disease, chronic respiratory
disease, and chronic liver disease.
§ Four patients reported history of either fatty liver or cirrhosis.
COVID-19, coronavirus disease 2019; LB, liver biochemistry; LBA, liver
biochemical abnormality; ALI, acute liver injury; LBAI, liver
biochemical abnormality or injury; ALT, alanine aminotransferase; AST,
aspartate aminotransferase; CURB-65, confusion, uremia, respiratory
rate, blood pressure, and age ≥65; IQR, interquartile range; NA, none
applicable; OR, odds ratio; CI, confidence interval; qSOFA, the Quick
Sequential Organ Failure Assessment.
|
Data are presented as medians (IQR) or n (%) according to the
corresponding conditions.
* All p values were calculated using univariate unconditional logistic
regression for the characteristics between the patients with normal
cumulative LB and those with cumulative LBAI, but two independent
samples (unpaired) Student’s t-test was used to compare the median ages.
** It is not applicable due to the no individuals with abnormal ALT or
AST or TBIL in Normal cumulative LB group.
†Referred to exposure to confirmed COVID-19 patients.
†† ORs were calculated using univariate unconditional logistic
regression.
‡Comorbidities were defined as history of at least one disease out of
the following: hypertension, diabetes, cardiovascular disease,
cerebrovascular disease, chronic renal disease, chronic respiratory
disease, and chronic liver disease.
§ Four patients reported history of either fatty liver or cirrhosis.
COVID-19, coronavirus disease 2019; LB, liver biochemistry; LBA, liver
biochemical abnormality; ALI, acute liver injury; LBAI, liver
biochemical abnormality or injury; ALT, alanine aminotransferase; AST,
aspartate aminotransferase; CURB-65, confusion, uremia, respiratory
rate, blood pressure, and age ≥65; IQR, interquartile range; NA, none
applicable; OR, odds ratio; CI, confidence interval; qSOFA, the Quick
Sequential Organ Failure Assessment.
|
Data are presented as medians (IQR) or n (%) according to the
corresponding conditions.
* All p values were calculated using univariate unconditional logistic
regression for the characteristics between the patients with normal
cumulative LB and those with cumulative LBAI, but two independent
samples (unpaired) Student’s t-test was used to compare the median ages.
** It is not applicable due to the no individuals with abnormal ALT or
AST or TBIL in Normal cumulative LB group.
†Referred to exposure to confirmed COVID-19 patients.
†† ORs were calculated using univariate unconditional logistic
regression.
‡Comorbidities were defined as history of at least one disease out of
the following: hypertension, diabetes, cardiovascular disease,
cerebrovascular disease, chronic renal disease, chronic respiratory
disease, and chronic liver disease.
§ Four patients reported history of either fatty liver or cirrhosis.
COVID-19, coronavirus disease 2019; LB, liver biochemistry; LBA, liver
biochemical abnormality; ALI, acute liver injury; LBAI, liver
biochemical abnormality or injury; ALT, alanine aminotransferase; AST,
aspartate aminotransferase; CURB-65, confusion, uremia, respiratory
rate, blood pressure, and age ≥65; IQR, interquartile range; NA, none
applicable; OR, odds ratio; CI, confidence interval; qSOFA, the Quick
Sequential Organ Failure Assessment.
|
Data are presented as medians (IQR) or n (%) according to the
corresponding conditions.
* All p values were calculated using univariate unconditional logistic
regression for the characteristics between the patients with normal
cumulative LB and those with cumulative LBAI, but two independent
samples (unpaired) Student’s t-test was used to compare the median ages.
** It is not applicable due to the no individuals with abnormal ALT or
AST or TBIL in Normal cumulative LB group.
†Referred to exposure to confirmed COVID-19 patients.
†† ORs were calculated using univariate unconditional logistic
regression.
‡Comorbidities were defined as history of at least one disease out of
the following: hypertension, diabetes, cardiovascular disease,
cerebrovascular disease, chronic renal disease, chronic respiratory
disease, and chronic liver disease.
§ Four patients reported history of either fatty liver or cirrhosis.
COVID-19, coronavirus disease 2019; LB, liver biochemistry; LBA, liver
biochemical abnormality; ALI, acute liver injury; LBAI, liver
biochemical abnormality or injury; ALT, alanine aminotransferase; AST,
aspartate aminotransferase; CURB-65, confusion, uremia, respiratory
rate, blood pressure, and age ≥65; IQR, interquartile range; NA, none
applicable; OR, odds ratio; CI, confidence interval; qSOFA, the Quick
Sequential Organ Failure Assessment.
|
Data are presented as medians (IQR) or n (%) according to the
corresponding conditions.
* All p values were calculated using univariate unconditional logistic
regression for the characteristics between the patients with normal
cumulative LB and those with cumulative LBAI, but two independent
samples (unpaired) Student’s t-test was used to compare the median ages.
** It is not applicable due to the no individuals with abnormal ALT or
AST or TBIL in Normal cumulative LB group.
†Referred to exposure to confirmed COVID-19 patients.
†† ORs were calculated using univariate unconditional logistic
regression.
‡Comorbidities were defined as history of at least one disease out of
the following: hypertension, diabetes, cardiovascular disease,
cerebrovascular disease, chronic renal disease, chronic respiratory
disease, and chronic liver disease.
§ Four patients reported history of either fatty liver or cirrhosis.
COVID-19, coronavirus disease 2019; LB, liver biochemistry; LBA, liver
biochemical abnormality; ALI, acute liver injury; LBAI, liver
biochemical abnormality or injury; ALT, alanine aminotransferase; AST,
aspartate aminotransferase; CURB-65, confusion, uremia, respiratory
rate, blood pressure, and age ≥65; IQR, interquartile range; NA, none
applicable; OR, odds ratio; CI, confidence interval; qSOFA, the Quick
Sequential Organ Failure Assessment.
|
Data are presented as medians (IQR) or n (%) according to the
corresponding conditions.
* All p values were calculated using univariate unconditional logistic
regression for the characteristics between the patients with normal
cumulative LB and those with cumulative LBAI, but two independent
samples (unpaired) Student’s t-test was used to compare the median ages.
** It is not applicable due to the no individuals with abnormal ALT or
AST or TBIL in Normal cumulative LB group.
†Referred to exposure to confirmed COVID-19 patients.
†† ORs were calculated using univariate unconditional logistic
regression.
‡Comorbidities were defined as history of at least one disease out of
the following: hypertension, diabetes, cardiovascular disease,
cerebrovascular disease, chronic renal disease, chronic respiratory
disease, and chronic liver disease.
§ Four patients reported history of either fatty liver or cirrhosis.
COVID-19, coronavirus disease 2019; LB, liver biochemistry; LBA, liver
biochemical abnormality; ALI, acute liver injury; LBAI, liver
biochemical abnormality or injury; ALT, alanine aminotransferase; AST,
aspartate aminotransferase; CURB-65, confusion, uremia, respiratory
rate, blood pressure, and age ≥65; IQR, interquartile range; NA, none
applicable; OR, odds ratio; CI, confidence interval; qSOFA, the Quick
Sequential Organ Failure Assessment.
|
Data are presented as medians (IQR) or n (%) according to the
corresponding conditions.
* All p values were calculated using univariate unconditional logistic
regression for the characteristics between the patients with normal
cumulative LB and those with cumulative LBAI, but two independent
samples (unpaired) Student’s t-test was used to compare the median ages.
** It is not applicable due to the no individuals with abnormal ALT or
AST or TBIL in Normal cumulative LB group.
†Referred to exposure to confirmed COVID-19 patients.
†† ORs were calculated using univariate unconditional logistic
regression.
‡Comorbidities were defined as history of at least one disease out of
the following: hypertension, diabetes, cardiovascular disease,
cerebrovascular disease, chronic renal disease, chronic respiratory
disease, and chronic liver disease.
§ Four patients reported history of either fatty liver or cirrhosis.
COVID-19, coronavirus disease 2019; LB, liver biochemistry; LBA, liver
biochemical abnormality; ALI, acute liver injury; LBAI, liver
biochemical abnormality or injury; ALT, alanine aminotransferase; AST,
aspartate aminotransferase; CURB-65, confusion, uremia, respiratory
rate, blood pressure, and age ≥65; IQR, interquartile range; NA, none
applicable; OR, odds ratio; CI, confidence interval; qSOFA, the Quick
Sequential Organ Failure Assessment.
|